The European Union has finally made a decisive decision and will not renew contracts for the purchase of vaccines from the Anglo-Swedish pharmaceutical Astrazeneca and the American Janssen (Johnson & Johnson), after the alleged side effects they have caused.
The news of the suspension of the Janssen administration had already upset the plans and forecasts of the different governments, who had great hope in this vaccine in order to advance the numbers of immunized people as much as possible, since it only requires one dose and It is also the one that takes the least time overall to provide immunity, two weeks, for four from Pfizer, six from Moderna or sixteen from AstraZeneca.
